Cancer Treatment in Outpatient Setting Reduces Cost, Maintains Clinical Quality

While patients undergoing radiation chemotherapy for advanced head and neck cancer in inpatient and outpatient settings experienced the same clinical outcomes, outpatients saw much lower costs, according to research by the Cleveland Clinic presented at the 2014 Multidisciplinary Head and Neck Symposium.

Advertisement

Although clinical outcomes were similar between the two study groups, the inpatient total cost per patient was approximately $18,000 more than the outpatient cost per patient.

Based on the study results, the Cleveland Clinic now recommends an outpatient radiation regime as the standard course of care for advanced head and neck cancers.

“Measuring the outcomes and cost of the two treatment regimens for a full cycle of care enabled us to change our practice pattern by appropriately reducing cost without sacrificing tumor outcomes,” said John Greskovich Jr., MD, radiation oncologist at Cleveland Clinic and lead author of the study, in a news release.

More Articles on Cancer Care:

Scripps Health Opens Proton Therapy Center for Cancer Care
MRI Detects Cancers as Effectively as PET-CT, Minus the Risks
Earlier Palliative Care Improves Cancer Patient Satisfaction

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Patient Safety & Outcomes

Advertisement

Comments are closed.